Clinical Outcomes of Aberration-Free All Surface Laser Ablation (ASLA) vs. Aberration-Free ASLA Assisted by Smart Pulse Technology in High Myopia: A One-Year Follow-Up Study
Table 1
Baseline preoperative valuesa.
Baseline preoperative values
SPT group
Non-SPT group
Number of eyes
53
85
Mean age (years)
26.25 ± 5.64
24.62 ± 4.91
0.082
Mean preoperative logMAR UDVA
1.294 ± 0.245
1.280 ± 0.269
0.725
Mean preoperative logMAR CDVA
−0.007 ± 0.017
−0.024 ± 0.034
0.02b
Mean preoperative refractive errors (D)
Sphere
−7.60 ± 1.31
−7.60 ± 1.06
0.925
Cylinder
−0.83 ± 0.64
−1.00 ± 0.71
0.206
Spherical equivalent
−8.02 ± 1.32
−8.10 ± 1.05
0.507
Optical zone diameter (mm)
6.12 ± 0.26
6.18 ± 0.26
0.494
Treatment diameter (mm)
7.91 ± 0.33
8.09 ± 0.33
0.001b
Ablation depth (μm)
160.85 ± 13.05
171.49 ± 11.25
<0.001b
Residual stromal bed thickness (μm)
345.83 ± 21.44
330.11 ± 18.71
<0.001b
SPT = smart pulse technology; UDVA = uncorrected distance visual acuity; CDVA = corrected distance visual acuity. aValues are presented as mean ± standard deviation. bSignificant difference between the SPT and non-SPT groups (Student’s t-test/Mann–Whitney U-test).